Feb 10, 2008 | NEWS
New risk variants published today will also be folded into deCODEme™ Reykjavik, ICELAND, February 10, 2008 – deCODE genetics (Nasdaq: DCGN) today announced the launch of deCODE PrCa™, a reference laboratory test for common, single-letter variations in the human...
Feb 7, 2008 | NEWS
Phenomenon could have long-term impact on population growth in urbanizing societies Reykjavik, February 7, 2008 – In a paper published today deCODE scientists establish a substantial and consistent positive correlation between the kinship of couples and the number of...
Jan 31, 2008 | NEWS
Reykjavik, ICELAND, January 31, 2008 – Scientists from deCODE genetics (Nasdaq:DCGN) today report the discovery of two common, single-letter variants in the sequence of the human genome (SNPs) that regulate one of the principle motors of evolution. Versions of the two...
Jan 9, 2008 | NEWS
Reykjavik, ICELAND, January 9, 2008 – deCODE genetics (Nasdaq:DCGN) today announced positive topline results from its Phase IIa clinical trial for DG051, the company’s leukotriene A4 hydrolase inhibitor being developed for the prevention of heart attack. With these...
Jan 6, 2008 | NEWS
Reykjavik, January 6, 2008 – deCODE scientists today report that the genetic variant on chromosome 9p21 that the company has linked to increased risk of heart attack is also associated with up to 70% increase in risk of abdominal aortic aneurysm (AAA) and intracranial...
